[ad_1]
United States Health Institutes, reported that thanks to studies with animals could be found that in two of the antibodies there is an important protection.
The researchers analyzed the blood plasma of 17 people who had recovered from Ebola, the antibodies of two survivors joined the glycoprotein also called GP, being this The Ebola virus uses GP to adhere to cell membranes and initiate an infection and, thanks to these antibodies, it is prevented from spreading to the brain. stop the viral entry into the host cell.
"The researchers conclude that these largely neutralizing antibodies are promising candidates for further development as therapeutic molecules against several species of Ebola," said the National Institutes of Health (NIH) of the United States.
The latest figures recorded by the World Health Organization (WHO) between 4 April and 9 July this year, reported that 53 cases were detected in the Democratic Republic of the Congo, of which they were were confirmed 38 and 29 of these people died, 24 of them recovered and survived the disease.
Source link
